Tech Company Financing Transactions

Abolis Biotechnologies Funding Round

Abolis Biotechnologies, based in Evry, secured $39 million from DeepTech & Climate Fonds, Evonik Venture Capital and L'Oreal BOLD Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Manufacturing

Mailing Address

Bâtiment 6, Genopole Campus 1, 5 Rue Henri Desbruères
Evry, 91030
France

Phone

Undisclosed

Website

www.abolis.fr

Email Address

Not Recorded

Overview

Abolis delivers high-impact innovations that support industries in their transition to build a better future in collaboration with nature. We provide tailor-made industrial solutions based on micro-organisms for a wide range of industries -- from food and healthcare to cosmetics and chemistry.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Cyrille Pauthenier

        

General Manager

Valérie Brunel

        

VP - Bus. Development

Gwenaël Servant

        

VP - Operations

Frédéric Austruy

        

Browse more venture capital transactions:

Prev: 9/13/2024: Regolith Labs venture capital transaction
Next: 9/13/2024: Newmi Care venture capital transaction

Share this article

Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary